HPLC Method for the Determination of Fenofibric Acid in Rat Plasma and its Application to a Comparative Pharmacokinetic Study of Prodrugs JWU 102 and Fenofibrate

Cardiovascular disease (CVD) and coronary heart disease (CHD) are leading causes of death in worldwide. Risk factors for CHD include elevated low-density lipoprotein cholesterol (LDL-C), elevated triglycerides, and decreased concentrations of high-density lipoprotein cholesterol (HDL-C) [1]. Due to the overwhelming evidence generated from outcome trials… CONTINUE READING